-
Mashup Score: 1COVID-19 Registry Dashboard | ECMO | ECLS - 4 month(s) ago
View details of ECMO-supported COVID-19 cases in the ELSO Registry, including COVID-19 ECMO counts by ELSO chapter. Filter patient data by region and patient age, plus view outcomes, pre-ECMO patient factors, pre-ECMO interventions, patient status and complication
Source: www.elso.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 13Bilateral Femoral Cannulation Is Associated With Reduced... : Critical Care Medicine - 4 month(s) ago
is preferable. DESIGN: A retrospective cohort study based on the Extracorporeal Life Support Organization registry. SETTING: ECMO centers worldwide included in the Extracorporeal Life Support Organization registry. PATIENTS: All adult patients (≥ 18 yr) who received peripheral venoarterial ECMO with femoral access and were included from 2014 to 2020. INTERVENTIONS: Unilateral or bilateral femoral cannulation. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the occurrence of limb ischemia defined as a composite endpoint including the need for a distal perfusion cannula (DPC) after 6 hours from implantation, compartment syndrome/fasciotomy, amputation, revascularization, and thrombectomy. Secondary endpoints included bleeding at the peripheral cannulation site, need for vessel repair, vessel repair after decannulation, and in-hospital death. Propensity score matching was performed to account for confounders. Overall, 19,093 patients underwent peripheral venoarterial ECMO through u
Source: journals.lww.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 13Bilateral Femoral Cannulation Is Associated With Reduced... : Critical Care Medicine - 4 month(s) ago
is preferable. DESIGN: A retrospective cohort study based on the Extracorporeal Life Support Organization registry. SETTING: ECMO centers worldwide included in the Extracorporeal Life Support Organization registry. PATIENTS: All adult patients (≥ 18 yr) who received peripheral venoarterial ECMO with femoral access and were included from 2014 to 2020. INTERVENTIONS: Unilateral or bilateral femoral cannulation. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the occurrence of limb ischemia defined as a composite endpoint including the need for a distal perfusion cannula (DPC) after 6 hours from implantation, compartment syndrome/fasciotomy, amputation, revascularization, and thrombectomy. Secondary endpoints included bleeding at the peripheral cannulation site, need for vessel repair, vessel repair after decannulation, and in-hospital death. Propensity score matching was performed to account for confounders. Overall, 19,093 patients underwent peripheral venoarterial ECMO through u
Source: journals.lww.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 18Predictors of thrombosis during VV ECMO: an analysis of 9809 patients from the ELSO registry - Journal of Thrombosis and Thrombolysis - 4 month(s) ago
Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a life-saving therapy for critically ill patients, but it carries an increased risk of thrombosis due to blood interacting with non-physiological surfaces. While the relationship between clinical variables and thrombosis remains unclear, our study aimed to identify which factors are most predictive of thrombosis. The Extracorporeal Life…
Source: link.springer.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 22
ingle-center, cohort study where all adult patients with viral etiology respiratory failure requiring VV-ECMO from January 2, 2015 to January 31, 2022 were included. Anticoagulation was monitored using aPTTr (until November 1, 2019) or anti-Xa assay (after November 1, 2019). We compared the accuracy and precision of anticoagulation monitoring tests using time in therapeutic range (TTR) and variance growth rate (VGR), respectively, and their impact on bleeding and thrombotic events (BTEs). A total of 254 patients, 74 in aPTTr and 180 in anti-Xa monitoring groups, were included with a total of 4,992 ECMO-person days. Accuracy was comparable: mean TTR of 47% in aPTTr and 51% in anti-Xa groups (p = 0.28). Antifactor Xa monitoring group demonstrated improved precision with a lower variance (median VGR 0.21 vs. 1.61 in aPTTr, p < 0.05). Secondary outcome of less heparin prescription changes (adjusted rate ratio [RR] = 1.01, p = 0.01), fewer blood transfusions (adjusted RR = 0.78, p < 0.05),
Source: journals.lww.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 13
erent methods: microbiological culture, scanning electron microscopy, and metagenomic (rRNA 16S analysis). A monocentric prospective study was conducted between December 2017 and June 2018. Consecutive patients undergoing VA-ECMO support for refractory cardiac arrest or cardiogenic shock were included. Ten patients were included with a median age of 64 (52–62) years. Venoarterial extracorporeal membrane oxygenation was inserted for refractory cardiac arrest in five (50%), cardiogenic shock in four (40%), and self-poisoning in one (10%) cases. Microbiological culture of all (8/8, 100%) membrane oxygenators was negative, whereas all (10/10, 100%) were colonized by biofilm, and eight (8/9, 89%) presented bacterial DNA. Three (3/9, 33%) arterial and venous cannulas were positive in culture and seven (7/9, 78%) were colonized by biofilm, respectively. Seven (7/9, 78%) arterial and four (4/9, 44%) venous cannulas presented bacterial DNA. Colonization of cannulas and membranes is more frequen
Source: journals.lww.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 21
ilation during ECMO may have potential advantages. We performed a systematic literature review to assess efficacy and safety of awake ECMO without invasive ventilation in patients with respiratory failure. DATA SOURCES: PubMed, Web of Science, and Scopus were searched for studies reporting outcome of awake ECMO for adult patients with respiratory failure. STUDY SELECTION: We included all studies reporting outcome of awake ECMO in patients with respiratory failure. Studies on ECMO for cardiovascular failure, cardiac arrest, or perioperative support and studies on pediatric patients were excluded. Two investigators independently screened and selected studies for inclusion. DATA EXTRACTION: Two investigators abstracted data on study characteristics, rate of awake ECMO failure, and mortality. Primary outcome was rate of awake ECMO failure (need for intubation). Pooled estimates with corresponding 95% CIs were calculated. Subgroup analyses by setting were performed. DATA SYNTHESIS: A total
Source: journals.lww.comCategories: General Medicine News, Critical CareTweet-
Awake #ECMO without invasive MV in respiratory failure, systematic review to assess efficacy/safety (📊 57 studies/data from 467 adults) 📈 feasible in selected pts but effect on outcome still to be demonstrated 📉 mortality almost 60% in pts who failed 📖 https://t.co/74v4eYI5Lq https://t.co/2vAeYb4N3p
-
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 0
HONOLULU — 2020 COVID-19 hospitalizations requiring extracorporeal membrane oxygenation cost significantly more and had lengthier stays than those that did not utilize ECMO, according to study results presented at the CHEST Annual Meeting.Use of ECMO also varied according to U.S. region and was more common in the first wave of the pandemic, Kam Sing Ho, MD, pulmonology and critical care
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet
RT @karag: #ECMO is trending - just a reminder that @ELSOOrg has a live dashboard of COVID cases treated with ECMO: https://t.co/5XBtyser0F…